Fazlur Rahman
Published September 13, 2026 - San Francisco, California. OpenAI and Anthropic are both preparing initial public offerings as of September 2026. OpenAI's IPO is widely expected in 2027 at a $500B-$800B valuation. Anthropic's IPO is expected in 2027-2028 at a $300B-$500B valuation. The preparations come amid the September 2026 AI safety debate, with both companies under pressure to demonstrate financial maturity and regulatory readiness (Reuters, September 13, 2026; Bloomberg, September 2026).
Data last verified September 13, 2026 from Reuters and Bloomberg reporting on September 12-13, 2026, prior 2025 funding round disclosures, and OpenAI and Anthropic public statements on revenue.
Quick Answer
OpenAI and Anthropic are both preparing IPOs. OpenAI target: 2027 at $500B-$800B. Anthropic target: 2027-2028 at $300B-$500B. Both are under pressure from the September 2026 AI safety debate to demonstrate regulatory readiness. OpenAI will likely IPO first (Reuters, September 13, 2026; Bloomberg, September 2026).
OpenAI's IPO path
OpenAI's most recent private valuation was $500B, set in a 2025 secondary share sale. The valuation reflects annualized revenue of $13B in 2026. The 2027 IPO is expected to value OpenAI at $500B-$800B. Investors in the private rounds include Microsoft, Thrive Capital, Sequoia Capital, Andreessen Horowitz, and the SoftBank Vision Fund. The Microsoft investment (now over $13B) is the deepest (Reuters, September 2026).
Anthropic's IPO path
Anthropic's most recent private valuation was $183B, set in a 2025 funding round. The valuation reflects annualized revenue of $7B in 2026. The 2027-2028 IPO is expected to value Anthropic at $300B-$500B. Investors include Google (up to $2B), Salesforce, Amazon, Spark Capital, and Menlo Ventures. The Google investment is the deepest (Reuters, September 2026).
Why the timing matters
The AI safety debate affects IPO timing. (1) Regulatory risk: stronger AI safety regulation could limit deployment. (2) Reputational risk: high-profile safety incidents affect public perception. (3) Public market investors demand more transparency than private market investors. Amodei's September 12 slowdown call is partly aimed at getting ahead of regulatory risk before the IPO window (Reuters, September 13, 2026).
Next steps
For the broader context, see our Amodei AI slowdown call and our AI news roundup September 13, 2026.
Related Coverage
Background and implications
The OpenAI and Anthropic IPO preparations are the largest tech IPO events on the horizon. OpenAI's expected $500B-$800B 2027 valuation would make it the most valuable US IPO in history, surpassing Saudi Aramco's 2019 listing ($1.7T at peak). Anthropic's $300B-$500B 2027-2028 valuation reflects its faster revenue growth and stronger safety positioning but smaller commercial footprint. Both companies are in pre-IPO stages: building out finance, legal, and IR teams; stress-testing 3-year audited financials; selecting lead underwriters (Goldman Sachs, Morgan Stanley, and JP Morgan are the top candidates for both); settling pre-IPO litigation (Anthropic's music-industry suits, OpenAI's New York Times suit). The IPO timing is tied to the September 2026 AI safety environment: both companies want to demonstrate financial maturity before regulatory scrutiny intensifies, and both need to capitalise on the current capability-and-revenue moment. Investor demand is expected to be 10-30x oversubscribed at the top of the range. Retail-investor allocation will be limited (typically 5-10% of IPO shares); institutional investors (sovereign wealth funds, pension funds, hedge funds) will dominate.
What this means for the AI industry and broader tech IPO market
The OpenAI and Anthropic IPOs will reshape the broader tech IPO market and the AI industry structure. Three second-order effects: (1) AI valuations become public-market benchmarks — once OpenAI trades at a known multiple, the entire AI sector (Anthropic, xAI, Mistral, Cohere, Hugging Face) gets marked to that multiple. Expect 2-5 more AI-lab IPOs in 2027-2029 (xAI most likely in 2028, Mistral 2028, Cohere 2029), (2) capital allocation shift — sovereign wealth funds (Saudi PIF, ADIA, GIC, Temasek) have been the marginal buyers of AI-lab secondary shares. After the IPOs, that capital will move to the public market. Pension funds and retail investors will provide the next demand wave, which is more price-sensitive, (3) the safety-vs-commercial tension becomes a public-market issue — once OpenAI and Anthropic are public, quarterly earnings calls will discuss safety R&D spending, capability disclosures, and regulatory engagement. Expect activist investors (Arjuna Capital, As You Sow) to file safety-related shareholder proposals. The 2027-2028 IPOs are not just exits; they are the public-market debut of the AI industry's accountability cycle (Reuters, Bloomberg, September 2026).
Pre-IPO litigation and regulatory milestones
Both OpenAI and Anthropic have unresolved pre-IPO issues. OpenAI: New York Times copyright suit (settlement -), authors class action (-), FTC and DOJ investigations. Anthropic: music industry suits (UMG, Sony, Warner, -), authors class action, residual discrimination suit. Both must also complete EU AI Act compliance audits (live since August 2026) before EU operations are validated. Pre-IPO milestones for 2027: 3-year audited financials, settled material litigation, SEC registration, S-1 filing, roadshow.
IPO timing remains the most consequential variable. Both companies are monitoring the September 16 FOMC meeting, the September 14 Oman-Iran-Gulf meeting, and the EU AI Office enforcement actions through Q4 2026. A clean macro window in Q1 2027 would allow OpenAI to file S-1 by April 2027 and price by September 2027. Anthropic targets Q4 2027 or Q1 2028.
Background and implications
The OpenAI and Anthropic IPO preparations are the largest tech IPO events on the horizon. OpenAI's expected $500B-$800B 2027 valuation would make it the most valuable US IPO in history, surpassing Saudi Aramco's 2019 listing ($1.7T at peak). Anthropic's $300B-$500B 2027-2028 valuation reflects its faster revenue growth and stronger safety positioning but smaller commercial footprint. Both companies are in pre-IPO stages: building out finance, legal, and IR teams; stress-testing 3-year audited financials; selecting lead underwriters (Goldman Sachs, Morgan Stanley, and JP Morgan are the top candidates for both); settling pre-IPO litigation (Anthropic's music-industry suits, OpenAI's New York Times suit). The IPO timing is tied to the September 2026 AI safety environment: both companies want to demonstrate financial maturity before regulatory scrutiny intensifies, and both need to capitalise on the current capability-and-revenue moment. Investor demand is expected to be 10-30x oversubscribed at the top of the range. Retail-investor allocation will be limited (typically 5-10% of IPO shares); institutional investors (sovereign wealth funds, pension funds, hedge funds) will dominate.
What this means for the AI industry and broader tech IPO market
The OpenAI and Anthropic IPOs will reshape the broader tech IPO market and the AI industry structure. Three second-order effects: (1) AI valuations become public-market benchmarks — once OpenAI trades at a known multiple, the entire AI sector (Anthropic, xAI, Mistral, Cohere, Hugging Face) gets marked to that multiple. Expect 2-5 more AI-lab IPOs in 2027-2029 (xAI most likely in 2028, Mistral 2028, Cohere 2029), (2) capital allocation shift — sovereign wealth funds (Saudi PIF, ADIA, GIC, Temasek) have been the marginal buyers of AI-lab secondary shares. After the IPOs, that capital will move to the public market. Pension funds and retail investors will provide the next demand wave, which is more price-sensitive, (3) the safety-vs-commercial tension becomes a public-market issue — once OpenAI and Anthropic are public, quarterly earnings calls will discuss safety R&D spending, capability disclosures, and regulatory engagement. Expect activist investors (Arjuna Capital, As You Sow) to file safety-related shareholder proposals. The 2027-2028 IPOs are not just exits; they are the public-market debut of the AI industry's accountability cycle (Reuters, Bloomberg, September 2026).
Pre-IPO litigation and regulatory milestones
Both OpenAI and Anthropic have unresolved pre-IPO issues. OpenAI: New York Times copyright suit (settlement -), authors class action (-), FTC and DOJ investigations. Anthropic: music industry suits (UMG, Sony, Warner, -), authors class action, residual discrimination suit. Both must also complete EU AI Act compliance audits (live since August 2026) before EU operations are validated. Pre-IPO milestones for 2027: 3-year audited financials, settled material litigation, SEC registration, S-1 filing, roadshow.
IPO timing remains the most consequential variable. Both companies are monitoring the September 16 FOMC meeting, the September 14 Oman-Iran-Gulf meeting, and the EU AI Office enforcement actions through Q4 2026. A clean macro window in Q1 2027 would allow OpenAI to file S-1 by April 2027 and price by September 2027. Anthropic targets Q4 2027 or Q1 2028.
Background and implications
The OpenAI and Anthropic IPO preparations are the largest tech IPO events on the horizon. OpenAI's expected $500B-$800B 2027 valuation would make it the most valuable US IPO in history, surpassing Saudi Aramco's 2019 listing ($1.7T at peak). Anthropic's $300B-$500B 2027-2028 valuation reflects its faster revenue growth and stronger safety positioning but smaller commercial footprint. Both companies are in pre-IPO stages: building out finance, legal, and IR teams; stress-testing 3-year audited financials; selecting lead underwriters (Goldman Sachs, Morgan Stanley, and JP Morgan are the top candidates for both); settling pre-IPO litigation (Anthropic's music-industry suits, OpenAI's New York Times suit). The IPO timing is tied to the September 2026 AI safety environment: both companies want to demonstrate financial maturity before regulatory scrutiny intensifies, and both need to capitalise on the current capability-and-revenue moment. Investor demand is expected to be 10-30x oversubscribed at the top of the range. Retail-investor allocation will be limited (typically 5-10% of IPO shares); institutional investors (sovereign wealth funds, pension funds, hedge funds) will dominate.
What this means for the AI industry and broader tech IPO market
The OpenAI and Anthropic IPOs will reshape the broader tech IPO market and the AI industry structure. Three second-order effects: (1) AI valuations become public-market benchmarks — once OpenAI trades at a known multiple, the entire AI sector (Anthropic, xAI, Mistral, Cohere, Hugging Face) gets marked to that multiple. Expect 2-5 more AI-lab IPOs in 2027-2029 (xAI most likely in 2028, Mistral 2028, Cohere 2029), (2) capital allocation shift — sovereign wealth funds (Saudi PIF, ADIA, GIC, Temasek) have been the marginal buyers of AI-lab secondary shares. After the IPOs, that capital will move to the public market. Pension funds and retail investors will provide the next demand wave, which is more price-sensitive, (3) the safety-vs-commercial tension becomes a public-market issue — once OpenAI and Anthropic are public, quarterly earnings calls will discuss safety R&D spending, capability disclosures, and regulatory engagement. Expect activist investors (Arjuna Capital, As You Sow) to file safety-related shareholder proposals. The 2027-2028 IPOs are not just exits; they are the public-market debut of the AI industry's accountability cycle (Reuters, Bloomberg, September 2026).
Pre-IPO litigation and regulatory milestones
Both OpenAI and Anthropic have unresolved pre-IPO issues. OpenAI: New York Times copyright suit (settlement -), authors class action (-), FTC and DOJ investigations. Anthropic: music industry suits (UMG, Sony, Warner, -), authors class action, residual discrimination suit. Both must also complete EU AI Act compliance audits (live since August 2026) before EU operations are validated. Pre-IPO milestones for 2027: 3-year audited financials, settled material litigation, SEC registration, S-1 filing, roadshow.
IPO timing remains the most consequential variable. Both companies are monitoring the September 16 FOMC meeting, the September 14 Oman-Iran-Gulf meeting, and the EU AI Office enforcement actions through Q4 2026. A clean macro window in Q1 2027 would allow OpenAI to file S-1 by April 2027 and price by September 2027. Anthropic targets Q4 2027 or Q1 2028.
Background and implications
The OpenAI and Anthropic IPO preparations are the largest tech IPO events on the horizon. OpenAI's expected $500B-$800B 2027 valuation would make it the most valuable US IPO in history, surpassing Saudi Aramco's 2019 listing ($1.7T at peak). Anthropic's $300B-$500B 2027-2028 valuation reflects its faster revenue growth and stronger safety positioning but smaller commercial footprint. Both companies are in pre-IPO stages: building out finance, legal, and IR teams; stress-testing 3-year audited financials; selecting lead underwriters (Goldman Sachs, Morgan Stanley, and JP Morgan are the top candidates for both); settling pre-IPO litigation (Anthropic's music-industry suits, OpenAI's New York Times suit). The IPO timing is tied to the September 2026 AI safety environment: both companies want to demonstrate financial maturity before regulatory scrutiny intensifies, and both need to capitalise on the current capability-and-revenue moment. Investor demand is expected to be 10-30x oversubscribed at the top of the range. Retail-investor allocation will be limited (typically 5-10% of IPO shares); institutional investors (sovereign wealth funds, pension funds, hedge funds) will dominate.
What this means for the AI industry and broader tech IPO market
The OpenAI and Anthropic IPOs will reshape the broader tech IPO market and the AI industry structure. Three second-order effects: (1) AI valuations become public-market benchmarks — once OpenAI trades at a known multiple, the entire AI sector (Anthropic, xAI, Mistral, Cohere, Hugging Face) gets marked to that multiple. Expect 2-5 more AI-lab IPOs in 2027-2029 (xAI most likely in 2028, Mistral 2028, Cohere 2029), (2) capital allocation shift — sovereign wealth funds (Saudi PIF, ADIA, GIC, Temasek) have been the marginal buyers of AI-lab secondary shares. After the IPOs, that capital will move to the public market. Pension funds and retail investors will provide the next demand wave, which is more price-sensitive, (3) the safety-vs-commercial tension becomes a public-market issue — once OpenAI and Anthropic are public, quarterly earnings calls will discuss safety R&D spending, capability disclosures, and regulatory engagement. Expect activist investors (Arjuna Capital, As You Sow) to file safety-related shareholder proposals. The 2027-2028 IPOs are not just exits; they are the public-market debut of the AI industry's accountability cycle (Reuters, Bloomberg, September 2026).
Pre-IPO litigation and regulatory milestones
Both OpenAI and Anthropic have unresolved pre-IPO issues. OpenAI: New York Times copyright suit (settlement -), authors class action (-), FTC and DOJ investigations. Anthropic: music industry suits (UMG, Sony, Warner, -), authors class action, residual discrimination suit. Both must also complete EU AI Act compliance audits (live since August 2026) before EU operations are validated. Pre-IPO milestones for 2027: 3-year audited financials, settled material litigation, SEC registration, S-1 filing, roadshow.
IPO timing remains the most consequential variable. Both companies are monitoring the September 16 FOMC meeting, the September 14 Oman-Iran-Gulf meeting, and the EU AI Office enforcement actions through Q4 2026. A clean macro window in Q1 2027 would allow OpenAI to file S-1 by April 2027 and price by September 2027. Anthropic targets Q4 2027 or Q1 2028.
Background and implications
The OpenAI and Anthropic IPO preparations are the largest tech IPO events on the horizon. OpenAI's expected $500B-$800B 2027 valuation would make it the most valuable US IPO in history, surpassing Saudi Aramco's 2019 listing ($1.7T at peak). Anthropic's $300B-$500B 2027-2028 valuation reflects its faster revenue growth and stronger safety positioning but smaller commercial footprint. Both companies are in pre-IPO stages: building out finance, legal, and IR teams; stress-testing 3-year audited financials; selecting lead underwriters (Goldman Sachs, Morgan Stanley, and JP Morgan are the top candidates for both); settling pre-IPO litigation (Anthropic's music-industry suits, OpenAI's New York Times suit). The IPO timing is tied to the September 2026 AI safety environment: both companies want to demonstrate financial maturity before regulatory scrutiny intensifies, and both need to capitalise on the current capability-and-revenue moment. Investor demand is expected to be 10-30x oversubscribed at the top of the range. Retail-investor allocation will be limited (typically 5-10% of IPO shares); institutional investors (sovereign wealth funds, pension funds, hedge funds) will dominate.
What this means for the AI industry and broader tech IPO market
The OpenAI and Anthropic IPOs will reshape the broader tech IPO market and the AI industry structure. Three second-order effects: (1) AI valuations become public-market benchmarks — once OpenAI trades at a known multiple, the entire AI sector (Anthropic, xAI, Mistral, Cohere, Hugging Face) gets marked to that multiple. Expect 2-5 more AI-lab IPOs in 2027-2029 (xAI most likely in 2028, Mistral 2028, Cohere 2029), (2) capital allocation shift — sovereign wealth funds (Saudi PIF, ADIA, GIC, Temasek) have been the marginal buyers of AI-lab secondary shares. After the IPOs, that capital will move to the public market. Pension funds and retail investors will provide the next demand wave, which is more price-sensitive, (3) the safety-vs-commercial tension becomes a public-market issue — once OpenAI and Anthropic are public, quarterly earnings calls will discuss safety R&D spending, capability disclosures, and regulatory engagement. Expect activist investors (Arjuna Capital, As You Sow) to file safety-related shareholder proposals. The 2027-2028 IPOs are not just exits; they are the public-market debut of the AI industry's accountability cycle (Reuters, Bloomberg, September 2026).
Pre-IPO litigation and regulatory milestones
Both OpenAI and Anthropic have unresolved pre-IPO issues. OpenAI: New York Times copyright suit (settlement -), authors class action (-), FTC and DOJ investigations. Anthropic: music industry suits (UMG, Sony, Warner, -), authors class action, residual discrimination suit. Both must also complete EU AI Act compliance audits (live since August 2026) before EU operations are validated. Pre-IPO milestones for 2027: 3-year audited financials, settled material litigation, SEC registration, S-1 filing, roadshow.
IPO timing remains the most consequential variable. Both companies are monitoring the September 16 FOMC meeting, the September 14 Oman-Iran-Gulf meeting, and the EU AI Office enforcement actions through Q4 2026. A clean macro window in Q1 2027 would allow OpenAI to file S-1 by April 2027 and price by September 2027. Anthropic targets Q4 2027 or Q1 2028.
